Global Nursing Impact of Immunotherapy in Lung Cancer

FDA’s New Tobacco Rule

IASLC WCLC 2016: Active Prevention, Accurate Diagnosis, Advanced Care

Osimertinib: A New Option in Non-Small Cell Lung Cancer - Q&A with David R. Gandara, MD, and Federico Cappuzzo, MD, PhD

Victorian Comprehensive Cancer Centre

Alectinib and ALK-Positive Non-Small Cell Lung Cancer - Q&A with Alice T. Shaw, MD, PhD, and Ranee Mehra, MD

What Have We Learned from the National Lung Screening Trial?

Small Cell Lung Cancer: The Next Challenge

2016 ASCO Annual Meeting

PD-L1 IHC Blueprint Project” Presented at the AACR Annual Meeting 2016

A Practical Approach to the Evaluation of Pulmonary Nodules